Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 15 May 2025

Study on the mechanism by which Xuanfu Hua Tang increases sensitivity of hepatocellular carcinoma cells to sorafenib by antagonizing the Notch1 pathway through HIF-2α

in Molecular and Cellular Oncology

Wenzhao Luo
Xian Li
Yiwan Shang
Zhen Chen
Yinglin Cui

Frontiers in Oncology

doi 10.3389/fonc.2025.1552480

140 views

Review

Accepted on 13 May 2025

Tight junctional protein family, Claudins (CLDNs) in cancer and cancer metastasis

in Molecular and Cellular Oncology

Wenxiao Ji
Xinguo Zhuang
Wen G. Jiang
Tracey A Martin

Frontiers in Oncology

doi 10.3389/fonc.2025.1596460

Mini Review

Accepted on 12 May 2025

Senescence-Associated Secretory Phenotype in Lung Cancer: Remodeling the Tumor Microenvironment for Metastasis and Immune Suppression

in Molecular and Cellular Oncology

Chen Chen
Ji Chen
Yanling Zhang
Qijun Zhang
Haixia SHI

Frontiers in Oncology

doi 10.3389/fonc.2025.1605085

Correction

Published on 12 May 2025

Corrigendum: Canmei formula reduces colitis-associated colorectal carcinogenesis in mice by modulating the composition of gut microbiota

in Molecular and Cellular Oncology

Huayue Zhang
Dengcheng Hui
Yuan Li
Guangsu Xiong
Xiaoling Fu

Frontiers in Oncology

doi 10.3389/fonc.2025.1609683

271 views

Original Research

Accepted on 06 May 2025

Comprehensive Simulations of Intracellular Electric Fields during Exposure to Tumor Treating Fields (TTFields)

in Molecular and Cellular Oncology

Kaida Liu
Ping Dai
Zirong Liu
Haohan Fang
Xing Li
Wei Gao

Frontiers in Oncology

doi 10.3389/fonc.2025.1520504

Review

Accepted on 06 May 2025

The Dual Effects of Macrophage-Derived Extracellular Vesicles on Tumor Cell Behavior: Mechanisms and Clinical Potential

in Molecular and Cellular Oncology

Jia-Wen Tian
Yu-Han Fang
He-Jing Zhang
Zi-Li Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1586083

Original Research

Accepted on 06 May 2025

Digital Spatial Profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer

in Molecular and Cellular Oncology

Samaneh Eickelschulte
Adam Kaczorowski
Florian Janke
Anja Lisa Riediger
Olga Lazareva
Sarah Böning
Glen Kristiansen
Constantin Schwab
Albrecht Stenzinger
Holger Sültmann

Frontiers in Oncology

doi 10.3389/fonc.2025.1572299

Original Research

Published on 06 May 2025

COP1 drives renal cell carcinoma progression by targeting ACSL4 for ubiquitin-mediated degradation and inhibiting ferroptosis

in Molecular and Cellular Oncology

Yuxiao Zheng
Lei Jiang
Feng Qi
Bo Peng

Frontiers in Oncology

doi 10.3389/fonc.2025.1570727

411 views

Review

Accepted on 05 May 2025

Current Trends in Theranostic Applications of Extracellular Vesicles in Cancer

in Molecular and Cellular Oncology

Yazan Almasry
Fayrouz Mustafa
Mohammed Alfuwais
Sara Alnachef
Hager Mohamed
Nusaibah S Gaber
Mohammed Imran Khan
Islam M Saadeldin
Ahmed Yaqinuddin

Frontiers in Oncology

doi 10.3389/fonc.2025.1592006

Review

Accepted on 30 Apr 2025

Application and recent advances in conventional biomarkers for the prognosis of papillary thyroid carcinoma

in Molecular and Cellular Oncology

Yanlin Chen
Muzi Li
Qiong Li
Cancan Zou
Qin Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1598934

Original Research

Accepted on 30 Apr 2025

Curcumin Inhibits Colorectal Cancer Progression by Targeting PTBP1 and CDK2-Mediated Pathways

in Molecular and Cellular Oncology

Hao Zheng
Shenglong Li
Ye Wang
Shuang Su
Yiheng Wang
Fujing Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1566889

Review

Accepted on 29 Apr 2025

Research Progress on the Cross-regulation Between Ferroptosis and Immunogenic Cell Death in Tumor Micro-environment

in Molecular and Cellular Oncology

Wei Tao Liu
yu chen jin
Han Sun
Wen Bo Xu
Yang Chen
rui han liang
Wang Lin Liu
Zengyu Zhang
Hui Ping Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1581951

104 views

Hypothesis and Theory

Accepted on 29 Apr 2025

Th17-to-Th1 Plasticity Under CTLA-4 Blockade: A Double-Edged Sword in Tumor Immunity and Mucosal Defense

in Molecular and Cellular Oncology

Arif Hakan ÖNDER
Mehmet Mutlu Çatlı
Kübra DEMİR ÖNDER

Frontiers in Oncology

doi 10.3389/fonc.2025.1607671

Review

Published on 29 Apr 2025

MYCN as an oncogene in pediatric brain tumors

in Molecular and Cellular Oncology

Adriana Fernandez Garcia
Jayden Jackson
Poorvi Iyer
Elissa G. Oliver
Kosuke Funato

Frontiers in Oncology

doi 10.3389/fonc.2025.1584978

634 views

Original Research

Accepted on 28 Apr 2025

METTL3-mediated SNHG1 m 6 A modification promotes proliferation and migration by transcriptional regulation of WDR74 in osteosarcoma

in Molecular and Cellular Oncology

Guanzhen Qiu
Yuxin Bao
Yuanzhuang Zhang
Yeqiu Xu
Tianhua Qiao
Chenghao Li
Hanjie Zhai
Zhenjun Chen
Fu Ren
Yong Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1529657

Original Research

Accepted on 28 Apr 2025

Multifactorial Risk Stratification for Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Predictive Model Integrating Clinical and Tumor Characteristics

in Molecular and Cellular Oncology

Huaiyu Yang
liyuan wei
jiaxin qian
Wensheng Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1586307